News from the healthcare data industry
AI-driven discovery platform enables new way to find novel pathways as well as progress towards identifying patients who may better respond to drugs in the clinic Preclinical data highlights the potential benefits of Exscientia’s AI-driven design to rapidly discover molecules with optimised properties, including GTAEXS-617 March 08, 2022 04:30 PM…
March 08, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, and Aetion, a global real-world evidence (RWE) technology and analytics provider, today announced a strategic partnership to develop a validated predictive model to identify patients with…
TUESDAY MARCH 8TH, 2022 Those without boosters nearly two times more likely to get COVID-19 during Omicron surge, with greater risk for those with co-morbidities BELLEVUE, Wash.– March 8, 2022 – Truveta, the health system-led company with a vision of saving lives with data, unveiled the Truveta platform in its…
Austin, Tx., McLean, Va., & Bedford, Mass., March 8, 2022—MITRE has joined Capital Factory’s Innovation Council (IC), which connects the world’s largest companies with the most innovative startups across Texas. MITRE will support the startup ecosystem with its deep technology and engineering expertise – collaborating and convening with other corporate and government innovators…
March 08, 2022 08:45 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data…
Ariel D Stern 1, Jan Brönneke 2, Jörg F Debatin 2, Julia Hagen 2, Henrik Matthies 2, Smit Patel 3, Ieuan Clay 4, Bjoern Eskofier 5, Annika Herr 6, Kurt Hoeller 7, Ashley Jaksa 8, Daniel B Kramer 9, Mattias Kyhlstedt 10, Katherine T Lofgren 11, Nirosha Mahendraratnam 12, Holger Muehlan 13, Simon Reif 14, Lars Riedemann 15, Jennifer C Goldsack 3 Affiliations 1Technology and Operations Management Unit, Harvard Business School, Boston, MA, USA; Health Innovation Hub, Berlin Germany; Digital Health Center, Hasso-Plattner Institute, Potsdam, Germany. Electronic…
Abstract Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. Current guidelines emphasize the importance of regular physical activity as a preventive measure against disease progression and as a valuable strategy for pain and functionality management. Despite this, most patients with osteoarthritis are inactive. Modern technological advances…
ABSTRACT BACKGROUND: Disparities in access, utilization and outcomes exist throughout the healthcare system for minority groups, including racial and ethnic minorities; these disparities have wide-reaching implications for individuals as well as the healthcare system as a whole. This study will examine the impact of race on short and medium term…
Treatment with eribulin (Halaven) elicited an estimated 2-year overall survival (OS) rate of 53.6% (95% CI, 35.1%-68.9%) for patients with metastatic breast cancer (MBC) previously treated with atezolizumab (Tecentriq) or sacituzumab govitecan (Trodelvy), according to real-world findings presented as a poster at the 39th Annual Miami Breast Cancer Conference®. “The treatment landscape…
When Robert Califf became the new commissioner of the U.S. Food & Drug Administration, he did so with a plan to emphasize the use of real-world evidence (RWE) in Agency decisions. So, even though the FDA has been evaluating the use of RWE and issued draft guidance a few months ago, “There’s still…